These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33025237)

  • 1. Use of Drug Release Testing to Evaluate the Retention of Abuse-Deterrent Properties of Polyethylene Oxide Matrix Tablets.
    Meruva S; Rezaei L; Thool P; Donovan MD
    AAPS PharmSciTech; 2020 Oct; 21(7):270. PubMed ID: 33025237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets.
    Rezaei L; Meruva S; Donovan MD
    AAPS PharmSciTech; 2021 Dec; 23(1):38. PubMed ID: 34961912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell.
    Boyce H; Smith D; Byrn S; Saluja B; Qu W; Gurvich VJ; Hoag SW
    AAPS PharmSciTech; 2018 May; 19(4):1744-1757. PubMed ID: 29582347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Drug-Polymer Interactions on Tablet Properties During the Development of Abuse-Deterrent Dosage Forms.
    Meruva S; Donovan MD
    AAPS PharmSciTech; 2019 Jan; 20(3):93. PubMed ID: 30690657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylene Oxide (PEO) Molecular Weight Effects on Abuse-Deterrent Properties of Matrix Tablets.
    Meruva S; Donovan MD
    AAPS PharmSciTech; 2019 Dec; 21(1):28. PubMed ID: 31858320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets.
    Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M
    Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential Oxycodone Loss of Physically Manipulated Abuse Deterrent Oxycodone HCl Extended Release Tablets Prepared for Nasal Insufflation Studies.
    Meng Z; Boyce HJ; Sun D; Kinjo M; Raofi S; Li T
    Pharm Res; 2021 Jul; 38(7):1263-1278. PubMed ID: 34128146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of Abuse-deterrent properties of PEO-based Abuse-deterrent formulation.
    Kibria G; Bandaranayake B; Zheng J; Lee S; Cruz C
    Int J Pharm; 2023 Jan; 631():122430. PubMed ID: 36493968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D printed opioid medicines with alcohol-resistant and abuse-deterrent properties.
    Ong JJ; Awad A; Martorana A; Gaisford S; Stoyanov E; Basit AW; Goyanes A
    Int J Pharm; 2020 Apr; 579():119169. PubMed ID: 32087263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse-deterrent features of an extended-release morphine drug product developed using a novel injection-molding technology for oral drug delivery.
    Skak N; Elhauge T; Dayno JM; Lindhardt K
    J Opioid Manag; 2017; 13(6):465-472. PubMed ID: 29308592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical Characterization of Thermally Annealed Tablets Containing Polyethylene Oxide for Abuse Deterrence.
    Tocce E; Bishop M; Balwinski K; Watson T; Lapham M; Hewlett K; Wontorcik A
    AAPS PharmSciTech; 2019 Nov; 21(1):2. PubMed ID: 31713019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
    Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets.
    Boyce HJ; Dave VS; Scoggins M; Gurvich VJ; Smith DT; Byrn SR; Hoag SW
    AAPS PharmSciTech; 2020 Jan; 21(3):86. PubMed ID: 31997096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of commercially available meth-deterrent pseudoephedrine hydrochloride products.
    Rahman Z; Aqueel MS; Korang-Yeboah M; Zidan AS; Chen J; Alayoubi AY; Cruz CN; Ashraf M
    Int J Pharm; 2020 Feb; 575():118909. PubMed ID: 31811923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator.
    Chen B; Zhang F; Dhupia J; Morgenstern MP; Costello M; Boyce H; Sun WJ; Raofi S; Tian L; Xu W
    AAPS PharmSciTech; 2023 Nov; 24(8):245. PubMed ID: 38030835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
    Shojaee S; Emami P; Mahmood A; Rowaiye Y; Dukulay A; Kaialy W; Cumming I; Nokhodchi A
    AAPS PharmSciTech; 2015 Dec; 16(6):1281-9. PubMed ID: 25771738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies.
    Yu D; Seelam RR; Zhang F; Byrn SR; Hoag SW
    J Pharm Sci; 2021 Jul; 110(7):2789-2799. PubMed ID: 33737019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of basket mesh size on the hydrodynamics of a partially filled (500 mL) USP rotating basket dissolution testing Apparatus 1.
    Sirasitthichoke C; Patel S; Reuter KG; Hermans A; Bredael G; Armenante PM
    Int J Pharm; 2024 Jun; 658():124209. PubMed ID: 38718973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.